Committed to advancing healthcare through science, education, and collaboration.

meiji
m-Lab
Disease

CKD-associated pruritus

CKD-associated pruritus medical illustration
Updated August 2026

Disease overview

CKD-aP can range from intermittent irritation to severe, widespread itch that disrupts sleep, mood, concentration and dialysis sessions. It often affects both sides of the body and may involve the back, arms, head or the arm with vascular access. Reporting the pattern and impact is important because clinicians may underestimate symptom burden and effective care usually requires more than one approach.

It includes:

  • Persistent itch in non-dialysis CKD
  • Haemodialysis- or peritoneal dialysis-associated itch
  • Sleep, mood and quality-of-life effects

Pathophysiology

No single mechanism explains CKD-aP. Current evidence points to interacting changes in immune signalling, peripheral nerves and opioid receptors, together with dry skin and the accumulation of substances not fully removed as kidney function declines. Mineral and bone disorder, inadequate dialysis and inflammation may contribute in some people, but a laboratory value alone does not confirm the diagnosis.

Disease pathway

Reduced kidney clearance
Immune and nerve signalling
Itch–sleep cycle
Assessment and tailored care

Common symptoms

Persistent or recurrent itch
Symmetrical or widespread symptoms
Dry skin
Night-time worsening
Disturbed sleep and fatigue
Reduced concentration or quality of life

Risk factors

Advanced CKD
Dialysis-related factors
Dry or vulnerable skin
Mineral and inflammatory factors

Assessment

Diagnosis starts with the person’s description of itch. The clinician examines the skin, reviews medicines and dialysis, and looks for dermatological, liver, thyroid, haematological, neurological or allergic causes. A symptom scale can document severity and response over time; blood tests are selected according to the clinical picture.

Assessment pathway

Map the itch
Exclude other causes
Review kidney care

Management

Management is individualized and often combines skin care, optimization of kidney treatment and medicines that act on itch signalling. Treatment choice depends on kidney function, dialysis status, other medicines, fall risk and local availability. Sedating antihistamines may help sleep in selected cases but CKD-aP is not primarily a histamine-driven condition.

Management approach

Protect the skin barrier
Optimize kidney treatment
Consider prescribed therapy
Seek prompt review

References

  1. National Kidney Foundation. Chronic Kidney Disease-Associated Pruritus fact sheet.
  2. National Kidney Foundation. Pruritus (Itchy Skin), reviewed 2026.
  3. Kidney Disease: Improving Global Outcomes. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
  4. Sukul N, et al. Pruritus in Hemodialysis Patients: Longitudinal Associations with Clinical and Patient-Reported Outcomes. American Journal of Kidney Diseases. 2023.

m-Lab account

Access your HCP account.

Sign in to approved HCP resources, discussions and restricted product material. New registrations require email verification, then manual review by the m-Lab administration team.